Raze Therapeutics
http://www.razetx.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Raze Therapeutics
Start-Up Execs On The Move, June 2015
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
How To Get 270 Approvals At Once? – Stealth's Rare Disease Strategy
With FDA’s blessing, Stealth BioTherapeutics is working toward a pivotal trial that would address an underlying cause, mitochondrial myopathy, of roughly 270 very rare diseases, potentially leading to an aggregate approval in all of those unmet medical needs.
Start-Up Execs On The Move, May 2015
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Execs On The Move, May 2015
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Raze Therapeutics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice